• Home
  • About
    • Group CEO
    • Management Team
    • Supervisory Board
    • Scientific Advisory Board
    • Affiliates
    • R&D Partnerships
    • Distributors
    • Quality Standards
    • Location
  • Services
    • Proteomics
    • Genomics Transcriptomics
    • Flow Cytometry
    • Assay Development
    • Monoclonal Antibodies
    • Biobanking
    • Custom Kit Production
    • OLINK Services
    • Biomarker Data Analyses
  • R&D
  • Products
    • MEMORYLINC
    • NEUROLINCS
    • FIMICS
    • BIOPRED
    • IVD Products
    • ELISA Kits
    • Recombinant Proteins
    • Monoclonal Abodies
    • Clinical Samples
  • Quality
  • Investors
    • Financial Management
    • Financial Data
    • Shareholders
  • Media
    • Press Releases
    • Media News
    • Newsletters
    • Posts
    • All Media
  • Careers
  • IFU APO-Easy
  • Copy of IFU APO-Easy
  • Stability APO-Easy
  • APO-Easy-FLS-OE02-01
  • APO-Easy-FLS-OE02-02
  • APO-Easy-FLS-OE02-03
Contact
Firalis
  • Home
  • About
  • Services
  • Products
  • R&D
  • Quality
  • Investors
  • Media

Firalis on « Les Echos »

« Les Echos », a prestigious financial journal, published an article on our collaboration with HTG Molecular Diagnostics about the development of a theranostic tool to predict response to anti‑TNFα therapies for Rheumatoid Arthritis (RA). Published on September 12th 2016.

 

Click on the link below to view the related press news:

 

https://www.lesechos.fr/2016/09/firalis-predit-lefficacite-des-therapies-contre-la-polyarthrite-rhumatoide-1112545

« Firalis prédit l'efficacité des thérapies contre la polyarthrite rhumatoïde »

13.03.2020

Contact Firalis

Firalis Group

© Copyright 2020 all rights reserved. 

The company logos, products and service marks are trademarks or registered trademarks of Firalis.

-----------------------------------------------------------------------------------------------------------------------

Information addressed to health professionals. The products presented on this site are for professional use only and, where applicable, comply with the requirements of the IVD Directive 98/79 / EC. Instructions for use must be consulted before using these products.

-----------------------------------------------------------------------------------------------------------------------

Headquarter : 17 Rue du Fort 68330 Huningue FRANCE